'Hijacker' drives cancer in some patients with high-risk neuroblastoma
by St. Jude Children's Research HospitalThe study authors (from left) Ying Shao, Yu Liu, PhD, and John Easton, PhD. Credit: Seth Dixon / St. Jude Children's Research HospitalResearchers h
Updated on: March 13,2024
19

'Hijacker' drives cancer in some patients with high-risk neuroblastoma
by St. Jude Children's Research HospitalThe study authors (from left) Ying Shao, Yu Liu, PhD, and John Easton, PhD. Credit: Seth Dixon / St. Jude Children's Research HospitalResearchers h
Updated on:March 13,2024
19
